Yuanzhen WANG, Hongyan WEI, Renhai TIAN, Yongzhen Chen, Danqing XU, Yingyuan ZHANG, Lixian CHANG, Chunyun LIU, Li LIU. Establishment and Evaluation of a Risk Prediction Model for Chronic Liver Failure Complicated by Primary Hepatocellular Carcinoma Before Intervention[J]. Journal of Kunming Medical University.
Citation: Yingfu LI, Ni GUO, Zhengguang LUO, Anhao XING, Taifu LI, Qianli MA. Correlation of EGFR Gene Polymorphisms with Non-small Cell Lung Cancer in Yunnan Han Population[J]. Journal of Kunming Medical University.

Correlation of EGFR Gene Polymorphisms with Non-small Cell Lung Cancer in Yunnan Han Population

  •   Objective  To investigate the correlation between the epidermal growth factor receptor (EGFR) gene polymorphisms and non-small cell lung cancer (NSCLC) in Yunnan Han population.   Methods  A total of 407 NSCLC patients and 526 healthy controls were included. Five SNPs (rs1050171, rs2072454, rs2227983, rs1140475 and rs2293347) in EGFR were genotyped using TaqMan assay. The association between SNPs and NSCLC, as well as pathological types, were analyzed.   Results  In dominant mode, rs2072454 C/T-T/T may be a risk factor for NSCLC (P = 0.004; OR = 1.50, 95% CI 1.14~1.96). There was a significant difference in genotype frequency between the SCC group and the control group (P = 0.007), but no difference in allele frequency after Bonferroni correction (P > 0.01); In the dominant mode, C/T-T/T at this locus relative to C/C was a risk for AC (P = 0.002; OR = 1.86, 95% CI 1.24~2.80). rs1050171 A/A had a significantly higher risk of SCC in recessive mode (P = 0.006, OR = 2.66, 95% CI 1.33~5.33). In dominant mode, rs2227983 A/G-G/G/G was a risk factor for the development of SCC relative to A/A (P = 0.007; OR = 1.83, 95% CI 1.15~2.89).   Conclusion  The SNPs rs2072454, rs1050171 and rs2227983 in EGFR gene may be associated with the risk of NSCLC development as well as the type of pathology in Yunnan Han population.
  • [1]
    Sung H,Ferlay J,Siegel R L,et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3):209-249. doi: 10.3322/caac.21660
    [2]
    Cao W,Chen H D,Yu Y W,et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl),2021,134(7):783-791. doi: 10.1097/CM9.0000000000001474
    [3]
    Alduais Y,Zhang H,Fan F,et al. Non-small cell lung cancer (NSCLC): A review of risk factors,diagnosis,and treatment[J]. Medicine (Baltimore),2023,102(8):e32899.
    [4]
    Shi Y X,Sheng D Q,Cheng L,et al. Current landscape of epigenetics in lung cancer: focus on the mechanism and application[J]. J Oncol,2019,2019:8107318.
    [5]
    Sabbah D A,Hajjo R,Sweidan K. Review on epidermal growth factor receptor (EGFR) structure,signaling pathways,interactions,and recent updates of EGFR inhibitors[J]. Curr Top Med Chem,2020,20(10):815-834. doi: 10.2174/1568026620666200303123102
    [6]
    Hata A N,Niederst M J,Archibald H L,et al. Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition[J]. Nat Med,2016,22(3):262-269. doi: 10.1038/nm.4040
    [7]
    Ma Y,Bao C,Kong R,et al. MicroRNA‑361‑5p suppresses cancer progression by targeting signal transducer and activator of transcription 6 in non‑small cell lung cancer[J]. Mol Med Rep,2015,12(5):7367-7373. doi: 10.3892/mmr.2015.4411
    [8]
    Voldborg B R,Damstrup L,Spang-Thomsen M,et al. Epidermal growth factor receptor (EGFR) and EGFR mutations,function and possible role in clinical trials[J]. Ann Oncol,1997,8(12):1197-1206. doi: 10.1023/A:1008209720526
    [9]
    He J,Huang Z,Han L,et al. Mechanisms and management of 3rd‑generation EGFR‑TKI resistance in advanced non‑small cell lung cancer[J]. Int J Oncol,2021,59(5):90. doi: 10.3892/ijo.2021.5270
    [10]
    Shi Y,Au J S,Thongprasert S,et al. A prospective,molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology[J]. J Thorac Oncol,2014,9(2):154-162. doi: 10.1097/JTO.0000000000000033
    [11]
    Yamamoto H,Toyooka S,Mitsudomi T. Impact of EGFR mutation analysis in non-small cell lung cancer[J]. Lung Cancer,2009,63(3):315-321. doi: 10.1016/j.lungcan.2008.06.021
    [12]
    Yatabe Y,Mitsudomi T. Epidermal growth factor receptor mutations in lung cancers[J]. Pathol Int,2007,57(5):233-244. doi: 10.1111/j.1440-1827.2007.02098.x
    [13]
    Jou Y S,Lo Y L,Hsiao C F,et al. Association of an EGFR intron 1 SNP with never-smoking female lung adenocarcinoma patients[J]. Lung Cancer,2009,64(3):251-256. doi: 10.1016/j.lungcan.2008.09.014
    [14]
    张云云,黄凤丹,马千里,等. CLPTM1L变异与云南汉族人群非小细胞肺癌的相关性[J]. 贵州医科大学学报,2022,47(5):524-529.
    [15]
    Sun T,Miao X,Zhang X,et al. Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma[J]. J Natl Cancer Inst,2004,96(13):1030-1036. doi: 10.1093/jnci/djh187
    [16]
    Arteaga C L. Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia [J]. Semin Oncol,2002,29(5 Suppl 14): 3-9.
    [17]
    Li Z X,Wang F,Sun Z Y,et al. Prognostic implications of the EGFR polymorphism rs763317 and clinical variables among young Chinese lung cancer population[J]. Neoplasma,2023,70(3):443-450. doi: 10.4149/neo_2023_230305N115
    [18]
    Saadeh F S,Mahfouz R,Assi H I. EGFR as a clinical marker in glioblastomas and other gliomas[J]. Int J Biol Markers,2018,33(1):22-32. doi: 10.5301/ijbm.5000301
    [19]
    Meng L Q. Essential role of polymorphism of Gab1,EGFR,and EGF for the susceptibility of biliary tract cancer[J]. Tumour Biol,2014,35(12):12497-12508. doi: 10.1007/s13277-014-2568-7
    [20]
    Chu H,Wang M,Jin H,et al. EGFR 3'UTR 774T>C polymorphism contributes to bladder cancer risk[J]. Mutagenesis,2013,28(1):49-55. doi: 10.1093/mutage/ges051
    [21]
    Bashir N A,Ragab E S,Khabour O F,et al. The association between epidermal growth factor receptor (EGFR) gene polymorphisms and lung cancer risk[J]. Biomolecules,2018,8(3):53. doi: 10.3390/biom8030053
    [22]
    Choi J E,Park S H,Kim K M,et al. Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: A case-control study[J]. BMC Cancer,2007,7:199. doi: 10.1186/1471-2407-7-199
    [23]
    Zhang J,Zhan Z,Wu J,et al. Association among polymorphisms in EGFR gene exons,lifestyle and risk of gastric cancer with gender differences in Chinese Han subjects[J]. PLoS One,2013,8(3):e59254. doi: 10.1371/journal.pone.0059254
    [24]
    Lawi Z K,Al-Shuhaib M B S,Amara I B,et al. Two missense variants of the epidermal growth factor receptor gene are associated with non small cell lung carcinoma in the subjects from Iraq[J]. Mol Biol Rep,2022,49(12):11653-11661. doi: 10.1007/s11033-022-07933-w
    [25]
    Baek I K,Cheong H S,Namgoong S,et al. Two independent variants of epidermal growth factor receptor associated with risk of glioma in a Korean population[J]. Sci Rep,2022,12(1):19014. doi: 10.1038/s41598-022-23217-6
    [26]
    Mustafa O H,Hamzeh A R,Ghabreau L,et al. Allele frequencies of the epidermal growth factor receptors polymorphism R521K in colorectal cancer patients and healthy subjects indicate a risk-reducing effect of K521 in Syrian population[J]. N Am J Med Sci,2013,5(3):202-206. doi: 10.4103/1947-2714.109189
    [27]
    Wu J,Zhang W,Xu A,et al. Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China[J]. Genet Test Mol Biomarkers,2013,17(8):595-600. doi: 10.1089/gtmb.2013.0031
    [28]
    Kallel I,Rebai M,Khabir A,et al. Genetic polymorphisms in the EGFR (R521K) and estrogen receptor (T594T) genes,EGFR and ErbB-2 protein expression,and breast cancer risk in Tunisia[J]. J Biomed Biotechnol,2009,2009:753683.
    [29]
    Obradović J,Djordjević N,Tošic N,et al. Frequencies of EGFR single nucleotide polymorphisms in non-small cell lung cancer patients and healthy individuals in the Republic of Serbia: A preliminary study[J]. Tumour Biol,2016,37(8):10479-10486. doi: 10.1007/s13277-016-4930-4
    [30]
    Saravani S,Parsamanesh N,Miri-Moghaddam E. Role of EGFR gene polymorphisms in oral squamous cell carcinoma patients of Southeast Iran: A case-control study[J]. Caspian J Intern Med,2020,11(4):391-397.
    [31]
    Mason R A,Morlock E V,Karagas M R,et al. EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis[J]. Carcinogenesis,2009,30(7):1155-1160. doi: 10.1093/carcin/bgp077
  • Relative Articles

    [1] Xueya CHEN, Jinmei XU, Zhi LI, Yan LIANG, Yufeng YAO, Fengquan HE, Zhiling YAN. The Association of HOXD-AS2 and MIR3142HG Gene Polymorphisms with Cervical Intraepithelial Neoplasia. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20241103
    [2] Zhixin NIU, Lihua TANG, Lei SHI, Chao HONG, Yufeng YAO, Zhiling YAN. Correlation of MAPK1 and NRAS Gene Polymorphisms with Cervical Intraepithelial Neoplasia in Yunnan Han Population. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20240502
    [3] Ni GUO, Cheng ZHANG, Chao HONG, Weipeng LIU, Yufeng YAO, Zhiling YAN. Correlation of KRAS Gene 3′ UTR Polymorphisms with Cervical Cancer and Cervical Intraepithelial Neoplasia in Chinese Han Population in Yunnan Province. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20240203
    [4] Caini ZHANG, Ya LI. A Meta-analysis of the Efficacy and Safety of Camrelizumab Combined with Chemotherapy in the Treatment of Non-small Cell Lung Cancer. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20240610
    [5] Chao HONG, Xudong XIANG, Yingfu LI, Yang CAO, Xueya CHEN, Shuai LI, Anhao XING, Mu LIN, Qianli MA. Association of Polymorphisms in the 3' UTR of Genes in the ERK1/2 Signaling Pathway with Non-small Cell Lung Cancer. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20240302
    [6] Yuhan SHI, Jing LI, Shuyuan LIU, Ting ZHAO, Jingsi YANG, Li SHI, Jiangli LIANG. Correlation of ERAP Gene Polymorphism with Antibody Response Induced by Sequential Immunization of Polio Vaccine. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20230711
    [7] Ji LI, Kunbin KE, Baiyu ZHANG, Yidao LIU, Jing BAI, Tao DONG, Zhencheng WANG, Deqiang QIN, Mengyue WANG, Hao LI. Association of Single Nucleotide Polymorphisms of Calcium Sensitive Receptor Gene with Calcium Nephrolithiasis and Hypercalciuria in Chinese Dai Population. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20230520
    [8] Tiantian CHENG, Wensa YIN, Jia WANG, Yumei LU, Xuanyu CHEN, Shengjie NIE, Linlin LIU. Association between TMTC1 Gene Polymorphisms and Schizophrenia. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20231014
    [9] Shujin LI, Yanfei YANG, Min SU, Yu LING, Yanqiong RAO, Jihua CUI. Single Nucleotide Polymorphisms in Children with Attention Deficit Hyperactivity Disorder Comorbid Emotion Problems. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20230420
    [10] Rongshuang WU, Jiangli PENG, Yonggang CHEN, Jie CHEN, Guowei MA, Xianrui LI, Xie LI, Chunhong YU. Associations between SLC2A9 Single Nucleotide Polymorphisms and Susceptibility to Pyrazinamide Induced Hyperuricemia. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20230409
    [11] Yan LIANG, Lei WANG, Ming LEI, Benchao CHEN, Ping SUN, Shuai LI, Li LIU, Qianrong WANG, Manlin LIAO, Qianli MA. Correlation between KRAS Gene Polymorphism and Non-small Cell Lung Cancer in Yunnan Han Population. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20230210
    [12] Cong MEI, Xiao-chun WENG, Bao-kun PENG, Sui-jun YAN, Chun LI, Qiong ZHOU, Zhe TANG. Correlation between rs4580704 Polymorphism of CLOCL Gene and Type 2 Diabetes and Sleep Quality. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20210332
    [13] Dong-yun LI, Shun-kui GANG, Jie LI, Ming-xing ZHANG, Lei LI. Association of ABCG2,SLC2A9,SLC17A3 and PRKG2 SNPs Variants with Gout in the Hani Population in China. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20210320
    [14] Jia YANG, Ya-xian LI, Ying-ying WANG, Lin XIAO, Chuan-yin LI, Fang TAN, Qian-li MA, Shu-yuan LIU. Association of the miR-149,miR-219 and miR-let-7 Polymorphisms with the Occurrence and Development of Non-small Cell Lung Cancer in a Chinese Han Population in Yunnan Province. Journal of Kunming Medical University,  doi: 10.12259/j.issn.2095-610X.S20211037
    [15] Liu Cheng Xiu . Association Study of TNF-α and ALCAM Polymorphisms with Chronic HCV Infection in Yunnan Han Population. Journal of Kunming Medical University,
    [16] Hong Chao . The Correlation of CDH13 Gren Variation with Non-small Cell Lung Cancer. Journal of Kunming Medical University,
    [17] Xiang Xi . The Correlation between Vitamin D Receptor Gene FokI Single Nucleotide Polymorphism and Diabetic Kidney Disease. Journal of Kunming Medical University,
    [18] Li Ying . . Journal of Kunming Medical University,
    [19] Liu Li Li . . Journal of Kunming Medical University,
    [20] Yang Xiao Lei . . Journal of Kunming Medical University,
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-03010203040
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 34.7 %FULLTEXT: 34.7 %META: 62.7 %META: 62.7 %PDF: 2.5 %PDF: 2.5 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 8.4 %其他: 8.4 %Falkenstein: 3.4 %Falkenstein: 3.4 %临沧: 2.5 %临沧: 2.5 %九江: 0.8 %九江: 0.8 %北京: 0.8 %北京: 0.8 %十堰: 1.7 %十堰: 1.7 %南通: 0.8 %南通: 0.8 %哥伦布: 0.8 %哥伦布: 0.8 %嘉兴: 0.8 %嘉兴: 0.8 %天津: 0.8 %天津: 0.8 %安康: 0.8 %安康: 0.8 %宣城: 0.8 %宣城: 0.8 %平顶山: 0.8 %平顶山: 0.8 %张家口: 10.1 %张家口: 10.1 %成都: 2.5 %成都: 2.5 %无锡: 0.8 %无锡: 0.8 %昆明: 5.9 %昆明: 5.9 %汉中: 2.5 %汉中: 2.5 %深圳: 2.5 %深圳: 2.5 %温州: 1.7 %温州: 1.7 %漯河: 2.5 %漯河: 2.5 %石家庄: 0.8 %石家庄: 0.8 %芒廷维尤: 29.4 %芒廷维尤: 29.4 %芜湖: 0.8 %芜湖: 0.8 %芝加哥: 0.8 %芝加哥: 0.8 %西宁: 8.4 %西宁: 8.4 %西安: 2.5 %西安: 2.5 %达州: 0.8 %达州: 0.8 %邯郸: 0.8 %邯郸: 0.8 %郑州: 1.7 %郑州: 1.7 %镇江: 0.8 %镇江: 0.8 %马鞍山: 0.8 %马鞍山: 0.8 %其他Falkenstein临沧九江北京十堰南通哥伦布嘉兴天津安康宣城平顶山张家口成都无锡昆明汉中深圳温州漯河石家庄芒廷维尤芜湖芝加哥西宁西安达州邯郸郑州镇江马鞍山

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(7)

    Article Metrics

    Article views (23) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return